This Pharmaceutical Executive Magazine article explores the intricate landscape for mergers and acquisitions and strategic partnerships in today’s high-stakes environment. Learn more about biopharma innovation and our insights from the 2024 Dealmakers’ Intentions Survey: pharmexec.com/view/twists-tu…

Dive into this Citeline article featuring our expert's insights from the 2024 Dealmakers' Intentions Survey on the funding environment, M&A and partnering: scrip.citeline.com/SC149635/Scrip… #SyneosHealth

ft. Neel Patel

The Digital Health Coalition gathered insights from thought leaders offering predictions on what lies ahead in 2024. Our expert shares her perspectives on the noteworthy advancements in pharma sales and marketing that unfolded in 2023. digitalhealthcoalition.org/insights/predi… #SyneosHealth

#AI and #machinelearning are here to stay. Join us on Monday 5th February at 9am CST, 3pm GMT, 4pm CET for a webinar by Syneos Health to understand how they can be used to the best effect in the evolving world of #clinicaltrials .

pharmaphorum.com/digital/how-ai…

💡 Discover the power of #FSP models for small companies! Join Syneos Health's webinar to learn how engaging w/ CROs can enhance competitiveness, offering improved oversight and optimized outcomes. 🔗 Register here: buff.ly/3TWBO4j

#DrugDevelopment #ClinicalOutsourcing

📰JUST LAUNCHED: 2024 Dealmakers' Intentions Survey. Download to learn more about 2024 expectations of biopharma decision-makers including increased focus on antibody-drug conjugates, #generativeAI products and cell & gene therapies. syneoshealth.com/insights-hub/d… #SyneosHealth

Join us for Global Mentoring Strategy at Syneos Health on Wednesday, January 17, 2024 at 9 am EST to hear how Syneos Health created an award-winning #mentoring program!

'CliQ In' and register today for this free event.
#NationalMentoringMonth #strategy
mentorcliq.com/mentorcom-spot…

The product portfolio of a #biopharma group is often split between assets backed by significant resources and ones that are less supported. Syneos Health shares one way to maintain and grow those less-supported assets: partnerships. Read more: ow.ly/aWnz50QlgUt

It's not enough for a #ClinicalTrial team to reach regulatory compliance. They must strive for regulatory excellence, fostering an environment of harmony and collaboration. Syneos Health provides tips on how you can get there. bit.ly/3NAmsP3

We’re excited to be joined by Hillary Bochniak, CHRO at Syneos Health who will be speaking at our Transformational CHRO Assembly at the Palmer House in Chicago. bit.ly/3QkFDP4

What steps can businesses take to minimize the risks associated with AI-generated content and ensure responsible and ethical usage? In this The Wall Street Journal article, our Chief Information & Digital Officer discusses the growing interest in responsible #AI : wsj.com/articles/compa…

Key #biotech leaders have come together with Syneos Health to share thoughts on the uncharted journey the #ClinicalTrial industry is taking through cell and gene therapy research. Read the recent survey results on the six biggest challenges: bit.ly/3tMSobR

Raymond Huml is the father of two children with #FSHD and he is also the head of Syneos Health #RareDiseaseConsortium . In his book he brings together an impressive range of experts to give their perspectives on the topic of #RareDiseaseDrugDevelopement .
bit.ly/RareDiseaseDru…

How are healthcare firms advancing the interlinked issues of gender parity, health equity and women’s financial status? Learn more from IMD about how organizations like #SyneosHealth are furthering women’s advancement in the workplace: imd.org/ibyimd/purpose… #IMDImpact

Today, we announced a new partnership with Syneos Health that is expanding access to available Syneos Health trials through Study Marketplace — increasing efficiencies for #clinicalresearch . Here are the details: ow.ly/WFGn50PTAlo

📰NEWS: #SyneosHealth appoints Colin Shannon as Chief Executive Officer. Together with Michelle Keefe, who remains on the Board and part of the executive leadership team, they will continue to drive the Company’s ongoing transformation: syneoshealth.com/news/releases/…

Syneos Health® is a fully integrated biopharmaceutical solutions organization built to accelerate customer success. They're also a 2023 #PM360Trailblazers Finalist - Supplier Company of the Year. Congrats - and see you at the Gala! bit.ly/3sUkPUB

What challenges persist in achieving equitable access to vaccines? Learn more about global health advancements, current vaccine pipeline and how the pandemic emphasized the need to address barriers to vaccine accessibility in this Pharmaceutical Executive Magazine article: pharmexec.com/view/global-va…

With thanks to Syneos Health for delivering their brilliant session on “Value inflection points” in product development which included an overview of market research required to prepare for each milestone to maximize value for the shareholders of the company.

#BioForward2023

📰NEWS: With nearly 30 years of experience, Dr. Terttu Haring joins #SyneosHealth to lead the global clinical operations organization in driving exceptional delivery, quality and data integrity for customers. investor.syneoshealth.com/news-releases/…